Correspondence 0001193125-23-244614 from enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc.
Date: Sept. 28, 2023 · CIK: 0001980845 · Accession: 0001193125-23-244614
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273851
Letter
Division of Corporate Finance Attention: Doris Stacey Gama VIA EDGAR Re: enGene Holdings Inc. Registration Statement on Form S-4 Filed August 9, 2023 File No. 333-273851
Dear Ms. Gama:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of Amendment No. 2 to the Registration Statement on Form S-4 (File No. 333-273851) (the “Registration Statement”) of enGene Holdings Inc. We respectfully request that the Registration Statement become effective as of 10:00 a.m., Eastern time, on September 29, 2023, or as soon as practicable thereafter.
Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Howard Kenny at +1.212.309.6843 or Thurston J. Hamlette at +1.212.309.6240.
Very Truly Yours,
enGene Holdings Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP enGene Holdings Inc. 7171 Rue Frederick Banting Saint-Laurent, QC H4S 1Z9, Canada September 28, 2023 U.S. Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 Attention: Doris Stacey Gama VIA EDGAR Re: enGene Holdings Inc. Registration Statement on Form S-4 Filed August 9, 2023 File No. 333-273851 Dear Ms. Gama: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of Amendment No. 2 to the Registration Statement on Form S-4 (File No. 333-273851) (the “Registration Statement”) of enGene Holdings Inc. We respectfully request that the Registration Statement become effective as of 10:00 a.m., Eastern time, on September 29, 2023, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Howard Kenny at +1.212.309.6843 or Thurston J. Hamlette at +1.212.309.6240. Very Truly Yours, enGene Holdings Inc. By: /s/ Jason D. Hanson Name: Jason D. Hanson Title: Chief Executive Officer cc: Morgan, Lewis & Bockius LLP